NO20080993L - Fremgangsmate for a forbedre arvakenhet - Google Patents

Fremgangsmate for a forbedre arvakenhet

Info

Publication number
NO20080993L
NO20080993L NO20080993A NO20080993A NO20080993L NO 20080993 L NO20080993 L NO 20080993L NO 20080993 A NO20080993 A NO 20080993A NO 20080993 A NO20080993 A NO 20080993A NO 20080993 L NO20080993 L NO 20080993L
Authority
NO
Norway
Prior art keywords
inheritance
improving
procedure
imidazolylalkyl
pyridines
Prior art date
Application number
NO20080993A
Other languages
English (en)
Norwegian (no)
Inventor
Christian N Lavedan
Mihael H Polymeropoulos
Original Assignee
Vanda Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanda Pharmaceuticals Inc filed Critical Vanda Pharmaceuticals Inc
Publication of NO20080993L publication Critical patent/NO20080993L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
NO20080993A 2005-07-29 2008-02-25 Fremgangsmate for a forbedre arvakenhet NO20080993L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70360405P 2005-07-29 2005-07-29
US73253605P 2005-11-02 2005-11-02
PCT/US2006/029112 WO2007016203A1 (fr) 2005-07-29 2006-07-26 Procede permettant d'ameliorer l'etat de veille

Publications (1)

Publication Number Publication Date
NO20080993L true NO20080993L (no) 2008-02-25

Family

ID=37708941

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080993A NO20080993L (no) 2005-07-29 2008-02-25 Fremgangsmate for a forbedre arvakenhet

Country Status (11)

Country Link
US (1) US20080280954A1 (fr)
EP (1) EP1919477B1 (fr)
JP (1) JP5017268B2 (fr)
KR (2) KR101146807B1 (fr)
AU (1) AU2006275824B2 (fr)
BR (1) BRPI0614701A2 (fr)
CA (1) CA2616177C (fr)
ES (1) ES2388876T3 (fr)
NO (1) NO20080993L (fr)
NZ (1) NZ565763A (fr)
WO (1) WO2007016203A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2642275A1 (fr) 2006-02-13 2007-08-23 Vanda Pharmaceuticals, Inc. Compositions de dosage stables d'imidazolylalkylpyridines
US20090105333A1 (en) * 2006-05-22 2009-04-23 Gunther Birznieks Melatonin agonist treatment
WO2009097414A1 (fr) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Utilisation d'imidazolylalkyl-pyridines pour le traitement de troubles addictifs
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR102593047B1 (ko) 2012-01-26 2023-10-24 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
EP2861244B1 (fr) * 2012-06-14 2018-09-19 The Regents Of The University Of Michigan Traitement d'apnée du sommeil
WO2014100292A1 (fr) 2012-12-18 2014-06-26 Vanda Pharmaceuticals Inc. Traitement de troubles du rythme circadien
CN103087019B (zh) * 2013-02-06 2015-02-04 济南志合医药科技有限公司 一种他司美琼的制备方法
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
DE4131584A1 (de) 1991-09-23 1993-03-25 Sandoz Ag Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
ES2175350T5 (es) 1996-03-08 2008-12-16 Takeda Pharmaceutical Company Limited Compuestos triciclicos que tienen afinidad de union a receptores de melatonina, su produccion y uso.
US20010034373A1 (en) 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
GB0009037D0 (en) 2000-04-13 2000-05-31 Novartis Ag Organic compounds
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US7528172B2 (en) 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia

Also Published As

Publication number Publication date
EP1919477A1 (fr) 2008-05-14
NZ565763A (en) 2010-12-24
HK1117402A1 (en) 2009-01-16
WO2007016203A1 (fr) 2007-02-08
CA2616177C (fr) 2012-05-01
KR101187461B1 (ko) 2012-10-02
JP5017268B2 (ja) 2012-09-05
JP2009502945A (ja) 2009-01-29
AU2006275824A1 (en) 2007-02-08
EP1919477A4 (fr) 2009-03-18
AU2006275824B2 (en) 2010-12-16
KR101146807B1 (ko) 2012-05-21
ES2388876T3 (es) 2012-10-19
BRPI0614701A2 (pt) 2011-04-12
KR20110011748A (ko) 2011-02-08
US20080280954A1 (en) 2008-11-13
KR20080033322A (ko) 2008-04-16
CA2616177A1 (fr) 2007-02-08
EP1919477B1 (fr) 2012-07-11

Similar Documents

Publication Publication Date Title
NO20080993L (no) Fremgangsmate for a forbedre arvakenhet
EA201291107A1 (ru) Соединения, ингибирующие металлоферменты
PH12013502623A1 (en) Metalloenzyme inhibitor compounds
PH12013502622A1 (en) Metalloenzyme inhibitor compounds
PH12013502624A1 (en) Metalloenzyme inhibitor compounds
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2011082245A3 (fr) Composés inhibiteurs de métallo-enzyme
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
WO2009036175A3 (fr) Inhibiteur de f1f0-atpase et procédés associés
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MY164646A (en) Nicotine lozenge compositions
WO2012064943A3 (fr) Composés inhibiteurs de métalloenzymes
IN2012DN03883A (fr)
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
TW200745109A (en) Pyrrolo-pyridine kinase modulators
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2007115821A3 (fr) Composés organiques
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20082298L (no) Kaliumkanalinhibitorer
MY159491A (en) Disubstituted phthalazine hedgehog pathway antagonists
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application